04 / 16
Start: 12:30
Start: 04/16/2010 - 12:30
End: 04/18/2010 - 22:00
Dates:
| ||
04 / 17
(all day)
Start: 04/16/2010 - 12:30
End: 04/18/2010 - 22:00
Dates:
| ||
04 / 18
End: 22:00
Start: 04/16/2010 - 12:30
End: 04/18/2010 - 22:00
Dates:
| ||
04 / 19
| ||
04 / 20
| ||
04 / 21
| ||
04 / 22
| ||
04 / 23
| ||
04 / 24
| ||
04 / 25
| ||
04 / 26
| ||
04 / 27
| ||
04 / 28
| ||
04 / 29
| ||
04 / 30
| ||
05 / 1
| ||
05 / 2
| ||
05 / 3
| ||
05 / 4
| ||
05 / 5
| ||
05 / 6
Start: 00:00
Start: 05/06/2010 - 00:00
End: 05/07/2010 - 23:59
The 27th Annual Clinical Virology Symposium and Annual Meeting of the Pan American Society for Clinical Virology will be held May 8 - 11, 2011 at the Hilton Daytona Beach Oceanfront Resort, Daytona Beach, FL. Available online now with links to abstracts! The Symposium will feature | ||
05 / 7
End: 23:59
Start: 05/06/2010 - 00:00
End: 05/07/2010 - 23:59
The 27th Annual Clinical Virology Symposium and Annual Meeting of the Pan American Society for Clinical Virology will be held May 8 - 11, 2011 at the Hilton Daytona Beach Oceanfront Resort, Daytona Beach, FL. Available online now with links to abstracts! The Symposium will feature | ||
05 / 8
| ||
05 / 9
| ||
05 / 10
| ||
05 / 11
| ||
05 / 12
| ||
05 / 13
| ||
05 / 14
Start: 12:00
Start: 05/14/2010 - 12:00
End: 05/15/2010 - 17:00
This course has been designed to further educate physicians and allied health professionals concerning the link between NSF and GBCA. A combination of keynote addresses, lectures, workshops, panel discussions, and poster presentations will provide a comprehensive overview of the clinico-pathologic characteristics of the disease, current therapeutic advances and treatment recommendations, including experimental therapies in clinical trials, the screening p | ||
05 / 15
End: 17:00
Start: 05/14/2010 - 12:00
End: 05/15/2010 - 17:00
This course has been designed to further educate physicians and allied health professionals concerning the link between NSF and GBCA. A combination of keynote addresses, lectures, workshops, panel discussions, and poster presentations will provide a comprehensive overview of the clinico-pathologic characteristics of the disease, current therapeutic advances and treatment recommendations, including experimental therapies in clinical trials, the screening p | ||
05 / 16
| ||